BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fakheri H, Bari Z, Aarabi M, Malekzadeh R. Helicobacter pylori eradication in West Asia: A review. World J Gastroenterol 2014; 20(30): 10355-10367 [PMID: 25132752 DOI: 10.3748/wjg.v20.i30.10355]
URL: https://www.wjgnet.com/1007-9327/full/v20/i30/10355.htm
Number Citing Articles
1
Muhammad Miftahussurur, Yoshio Yamaoka. Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian PerspectiveMolecules 2015; 20(4): 6068 doi: 10.3390/molecules20046068
2
L. M. Lawson-Ananissoh, O. Bouglouga, A. Bagny, R. El-Hadj Yakoubou, L. Kaaga, D. Redah. Profil épidémiologique des ulcères gastro-duodénaux au centre hospitalier et universitaire Campus de Lomé (Togo)Journal Africain d'Hépato-Gastroentérologie 2015; 9(3): 99 doi: 10.1007/s12157-015-0597-5
3
Bahareh Attaran, Tahereh Falsafi, Nassim Ghorbanmehr. Effect of biofilm formation by clinical isolates of <i>Helicobacter pylori</i> on the efflux-mediated resistance to commonly used antibioticsWorld Journal of Gastroenterology 2017; 23(7): 1163-1170 doi: 10.3748/wjg.v23.i7.1163
4
Samin Alihosseini, Reza Ghotaslou, Fatemah Sadeghpour Heravi, Zainab Ahmadian, Hamed Ebrahimzadeh Leylabadlo. Management of antibiotic-resistantHelicobacter pyloriinfection: current perspective in IranJournal of Chemotherapy 2020; 32(6): 273 doi: 10.1080/1120009X.2020.1790889
5
Muhammad Miftahussurur, Yoshio Yamaoka. Helicobacter pylori Research2016; : 519 doi: 10.1007/978-4-431-55936-8_23
6
Akihiko Komuro. Japanese Kampo Medicines for the Treatment of Common Diseases: Focus on Inflammation2017; : 127 doi: 10.1016/B978-0-12-809398-6.00014-7
7
Ya-Wen Zhang, Wei-Ling Hu, Yuan Cai, Wen-Fang Zheng, Qin Du, John J Kim, John Y Kao, Ning Dai, Jian-Min Si. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for <i>Helicobacter pylori</i> infection and predictors of failed eradicationWorld Journal of Gastroenterology 2018; 24(40): 4596-4605 doi: 10.3748/wjg.v24.i40.4596
8
Marjan Mohammadi, Bahareh Attaran, Reza Malekzadeh, David Y. Graham. Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from IranDigestive Diseases and Sciences 2017; 62(8): 1890 doi: 10.1007/s10620-017-4628-5
9
Alireza Bakhshipour, Narges Mohsenpour Mohammadi, Seyed Mahdi Hashemi, Mohammad Kazem Momeni. Comparison of Clarithromycin-based Triple Therapy and Furazolidone-based Quadruple Therapy in Eradicating Helicobacter pylori InfectionInternational Journal of Infection 2021; 8(1) doi: 10.5812/iji.98954
10
Hamid Abdollahi, Mohammad Hashemzadeh, Saeed Khoshnood, Mohammad Savari. Characterization of Helicobacter pylori genotypes from Iranian patients with gastric clinical diseases: Predominance of vacA s1a and cagA EPIYA-ABC genotypesGene Reports 2019; 16: 100458 doi: 10.1016/j.genrep.2019.100458
11
Atieh Makhlough, Hafez Fakheri, Samaneh Hojati, Vahid Hosseini, Zohreh Bari. A Comparison between Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Eradication in Patients with Uremia: A Randomized Clinical TrialMiddle East Journal of Digestive Diseases 2015; 8(1): 39 doi: 10.15171/mejdd.2016.05
12
Leila Lormohammadi, Farhad Nikkhahi, Shahin Bolori, Ali Akbar Karami, Sepideh Hajian, Neda Rad, Amir Peymani, Rasoul Samimi. High level of resistance to metronidazole and clarithromycin among Helicobacter pylori clinical isolates in Qazvin province, IranGene Reports 2022; 26: 101494 doi: 10.1016/j.genrep.2022.101494
13
Reza Khashei, Mahintaj Dara, Abdollah Bazargani, Kamran Bagheri Lankarani, Alireza Taghavi, Maryam Moeini, Behzad Dehghani, Maryam Sohrabi. High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolatesAPMIS 2016; 124(9): 787 doi: 10.1111/apm.12567
14
Laleh Mahmoudi, Shohreh Farshad, Mehrdad Seddigh, Paria Mahmoudi, Fardad Ejtehadi, Ramin Niknam. High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradicationMedicine 2016; 95(42): e4410 doi: 10.1097/MD.0000000000004410
15
Su Young Kim, Duck Joo Choi, Jun-Won Chung. Antibiotic treatment for <italic>Helicobacter pylori</italic>: Is the end coming?World Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 183-198 doi: 10.4292/wjgpt.v6.i4.183
16
Hafez Fakheri, Mehdi Saberi Firoozi, Zohreh Bari. Eradication of Helicobacter Pylori in Iran: A ReviewMiddle East Journal of Digestive Diseases 2017; 10(1): 5 doi: 10.15171/mejdd.2017.84
17
Hassan Salmanroghani, Massoud Mirvakili, Mahmud Baghbanian, Roham Salmanroghani, Golshid Sanati, Pouria Yazdian, John Green. Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical TrialPLOS ONE 2018; 13(6): e0197096 doi: 10.1371/journal.pone.0197096
18
Leila Manzouri, Farzaneh Zarei, Narjes Niazi, Moslem Sedaghattalab. Comparison of the Success Rate of Quadruple and Triple Antibiotic Therapy in Eradicating Helicobacter pylori Infection in Southwest of Iran: A Randomized Clinical TrialInternational Journal of Infection 2017; 4(3) doi: 10.5812/iji.15610
19
Parisa Abedi Elkhichi, Masoumeh Aslanimehr, Adeleh Atar. A SYSTEMATIC REVIEW OF THE TREATMENT OF HELICOBACTER PYLORI BY THE EFFECT OF PROBIOTICS IN ASIAN POPULATIONStudies in Medical Sciences 2023; 34(3): 116 doi: 10.61186/umj.34.3.116